Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$37.32 - $49.29 $359,652 - $475,007
9,637 New
9,637 $363,000
Q1 2023

May 12, 2023

BUY
$37.58 - $52.57 $70,387 - $98,463
1,873 Added 34.58%
7,290 $295,000
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $269,224 - $312,615
5,417 New
5,417 $276,000
Q2 2022

Aug 12, 2022

SELL
$63.83 - $80.0 $309,511 - $387,920
-4,849 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$76.85 - $89.45 $2.71 Million - $3.15 Million
-35,258 Reduced 87.91%
4,849 $376,000
Q4 2021

Feb 11, 2022

BUY
$74.57 - $87.19 $2.99 Million - $3.5 Million
40,107 New
40,107 $3.44 Million
Q3 2021

Nov 12, 2021

SELL
$73.77 - $83.61 $11.3 Million - $12.8 Million
-152,872 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $10.5 Million - $11.5 Million
130,649 Added 587.9%
152,872 $12.3 Million
Q1 2021

May 06, 2021

BUY
$76.38 - $86.03 $1.7 Million - $1.91 Million
22,223 New
22,223 $1.87 Million
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $5.2 Million - $5.68 Million
-69,016 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $5.41 Million - $6.26 Million
69,016 New
69,016 $5.55 Million
Q1 2020

May 14, 2020

SELL
$71.57 - $93.3 $2.64 Million - $3.44 Million
-36,903 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $1.72 Million - $1.99 Million
22,456 Added 155.44%
36,903 $3.09 Million
Q3 2019

Nov 12, 2019

BUY
$81.4 - $89.78 $1.18 Million - $1.3 Million
14,447 New
14,447 $1.26 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $742,184 - $832,835
-10,106 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $651,634 - $821,718
10,106 New
10,106 $822,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.